Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial

Table 1

General characteristics of participants.

Variable	SJDBT group	Placebo group	p value
	Mean ± SD	Mean ± SD
Age			0.718
Gender
Male	1 (6.2%)	1 (6.2%)	1.000
Female	15 (93.8%)	15 (93.8%)
Anthropometric measurements
Height, cm			0.178
Weight, kg			0.831
BMI			0.424
FAACT scale			0.942
FAACT ACS scale			0.711
Anorexia VAS			0.937
Systolic blood pressure (SBP), mmHg			0.275
Diastolic blood pressure (DBP), mmHg			0.168
Pulse, bpm			0.929
ACTH			0.771
Cortisol			0.995
Ghrelin			0.528
Interleukin 6			0.883
ESR			0.717
CRP			0.983
Cancer type
Breast cancer	3 (18.8%)	4 (25.0%)	0.267
Cervical cancer	2 (12.5%)	0 (0.0%)
Colon cancer	1 (6.2%)	1 (6.2%)
Gastric cancer	3 (18.8%)	0 (0.0%)
Lung cancer	1 (6.2%)	3 (18.8%)
Thyroid cancer	6 (37.5%)	8 (50.0%)
Anticancer therapy
Chemo- and radiotherapy	3 (18.8%)	0 (0.0%)	0.239
Chemotherapy only	3 (18.8%)	4 (25.0%)
Radiotherapy only	3 (18.8%)	6 (37.5%)
None	7 (43.8%)	6 (37.5%)